Alibaba Health Information Technology Limited (ALBHF)
- Previous Close
0.0000 - Open
0.7754 - Bid 0.5795 x --
- Ask 0.6372 x --
- Day's Range
0.7754 - 0.7754 - 52 Week Range
0.3200 - 0.8000 - Volume
491 - Avg. Volume
1,459 - Market Cap (intraday)
10.073B - Beta (5Y Monthly) 1.02
- PE Ratio (TTM)
62.60 - EPS (TTM)
0.0100 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. The company offers a range of prescription and over-the-counter drugs, nutritional supplements, medical devices, contact lenses, health food, adult and family planning products, healthcare and skincare products, and various other health-related products. It also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, appointment-booking, vaccination, dental care, mental care, optometry, and nursing services, as well as traditional Chinese medicines. The company provides is products and services to business-to-customer and business-to-business customers through offline pharmacy outlets, as well as online stores, such as Tmall, Taobao, Alipay, Ele.me, AMap, DingTalk, Freshippo, and Quark. In addition, it engages in the digital tracking business; provision of network hospital, software technical services, healthcare related internet information and technical services; operation of internet hospitals, as well as Doctor U, an intelligent and one-stop platform for doctor and patient education; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
www.alihealth.cn1,435
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: ALBHF
View MorePerformance Overview: ALBHF
Trailing total returns as of 10/9/2024, which may include dividends or other distributions. Benchmark is
.YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALBHF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALBHF
View MoreValuation Measures
Market Cap
9.66B
Enterprise Value
8.31B
Trailing P/E
70.07
Forward P/E
25.00
PEG Ratio (5yr expected)
0.83
Price/Sales (ttm)
2.29
Price/Book (mrq)
4.86
Enterprise Value/Revenue
2.16
Enterprise Value/EBITDA
58.36
Financial Highlights
Profitability and Income Statement
Profit Margin
3.27%
Return on Assets (ttm)
1.97%
Return on Equity (ttm)
5.95%
Revenue (ttm)
27.03B
Net Income Avi to Common (ttm)
883.48M
Diluted EPS (ttm)
0.0100
Balance Sheet and Cash Flow
Total Cash (mrq)
9.55B
Total Debt/Equity (mrq)
0.57%
Levered Free Cash Flow (ttm)
320.32M
Company Insights: ALBHF
ALBHF does not have Company Insights